Warner Pharmaceutical announced that the company participated in the centralized procurement organized by the National Chinese Patent Medicine Joint Procurement Office (first batch expansion continuation) and the centralized procurement of medical drugs and devices organized by the Hebei Medical Drug and Device Central Procurement Center, leading the JING-JIN-JI and Jiangxi chemical drug centralized bulk procurement. According to the announcement released by relevant departments, the company's Silver Ginkgo Blade, Fosfomycin Ammonium and Dexamethasone Sodium Phosphate Sustained Release Tablets are expected to win bids. This planned bidding will be beneficial for improving drug accessibility, promoting the company's related product expansion, and enhancing the company's brand influence. However, there is still uncertainty regarding subsequent matters such as the signing of procurement contracts and market sales execution.